X 
Board Meetings
Home | Market Info | Company Profile | Board Meetings
Nagreeka Exports Ltd.
BSE CODE: 521109   |   NSE CODE: NAGREEKEXP   |   ISIN CODE : INE123B01028   |   26-Dec-2025 Hrs IST
BSE NSE
Rs. 28.83
1.6 ( 5.88% )
 
Prev Close ( Rs.)
27.23
Open ( Rs.)
27.00
 
High ( Rs.)
28.83
Low ( Rs.)
25.51
 
Volume
1603
Week Avg.Volume
1054
 
52 WK High-Low Range(Rs.)
BSE NSE
Rs. 26.59
-0.07 ( -0.26% )
 
Prev Close ( Rs.)
26.66
Open ( Rs.)
26.30
 
High ( Rs.)
27.44
Low ( Rs.)
26.30
 
Volume
12374
Week Avg.Volume
8460
 
52 WK High-Low Range(Rs.)
22.5
43.5
Source DateBoard Meeting DateDetails
13-Nov-2025 18-Nov-2025 Increase in Authorised Capital Inter alia, to transact the following major businesses: 1. To Increase the Authorised Capital of the company from Rs. 35.00 crore to Rs. 50.00 Crore. 2. To change the Clause V - Authorised Capital of Memorandum of Association accordingly. 3. Any other business as Board deem fit to discuss, with the permission of the Chairman.
04-Nov-2025 14-Nov-2025 Quarterly Results
26-Sep-2025 01-Oct-2025 Rights Issue inter-alia, to transact the following:- a. To consider fund raising by way of an issuance of equity shares to its eligible equity shareholders on a rights basis (?Rights issue?) subject to receipt of necessary approvals from Regulatory Authorities, as applicable and in accordance with applicable provision of the Companies Act, 2013, as amended, Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended, and other applicable laws; Details of the proposal shall be intimated in the outcome of the meeting; b. To consider and approve the Draft Letter of Offer for fund raising by way of Right issue and to authorize for Application for in-principal approval for rights issue up to 350,00,00,000.00/- under Regulation 28(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. c. To consider and approve any other matter incidental and connected thereto.
04-Aug-2025 13-Aug-2025 Quarterly Results
04-Aug-2025 13-Aug-2025 Quarterly Results
19-May-2025 29-May-2025 Audited Results
08-May-2025 16-May-2025 Increase in Authorised Capital
04-Feb-2025 13-Feb-2025 Quarterly Results & Right Issue of Equity Shares
05-Nov-2024 14-Nov-2024 Audited Results
02-Aug-2024 13-Aug-2024 Quarterly Results
Page 1 of 11
PREV || NEXT